The prospective role of mesenchymal stem cells in Parkinson's disease

IF 3.1 3区 医学 Q2 CLINICAL NEUROLOGY Parkinsonism & related disorders Pub Date : 2024-10-01 DOI:10.1016/j.parkreldis.2024.107087
Pratima Tambe , Vaishali Undale , Avinash Sanap , Ramesh Bhonde , Nishant Mante
{"title":"The prospective role of mesenchymal stem cells in Parkinson's disease","authors":"Pratima Tambe ,&nbsp;Vaishali Undale ,&nbsp;Avinash Sanap ,&nbsp;Ramesh Bhonde ,&nbsp;Nishant Mante","doi":"10.1016/j.parkreldis.2024.107087","DOIUrl":null,"url":null,"abstract":"<div><div>Parkinson's disease (PD) is a stressful neurodegenerative disorder affecting millions worldwide. PD leads to debilitating motor and cognitive symptoms such as tremors, rigidity, and difficulty walking. Current therapies for PD are symptomatic and don't address the root cause. Therefore, there is an urgent need for better management and intensive research into alternative therapies. Mesenchymal stem cell (MSC) therapy is among the leading contenders among these promising avenues. We examined preclinical and clinical evidence demonstrating the neuroprotective, anti-inflammatory, and regenerative properties of the MSCs. This review focuses on the complex pathophysiological mechanisms of PD, as well as the perspectives of MSCs and their derivatives, such as secretomes and exosomes, in the clinical management of PD. We also analyzed the challenges and limitations of each approach, including delivery methods, timing of administration, and long-term safety considerations.</div></div>","PeriodicalId":19970,"journal":{"name":"Parkinsonism & related disorders","volume":"127 ","pages":"Article 107087"},"PeriodicalIF":3.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinsonism & related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S135380202401099X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Parkinson's disease (PD) is a stressful neurodegenerative disorder affecting millions worldwide. PD leads to debilitating motor and cognitive symptoms such as tremors, rigidity, and difficulty walking. Current therapies for PD are symptomatic and don't address the root cause. Therefore, there is an urgent need for better management and intensive research into alternative therapies. Mesenchymal stem cell (MSC) therapy is among the leading contenders among these promising avenues. We examined preclinical and clinical evidence demonstrating the neuroprotective, anti-inflammatory, and regenerative properties of the MSCs. This review focuses on the complex pathophysiological mechanisms of PD, as well as the perspectives of MSCs and their derivatives, such as secretomes and exosomes, in the clinical management of PD. We also analyzed the challenges and limitations of each approach, including delivery methods, timing of administration, and long-term safety considerations.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
间充质干细胞在帕金森病中的前瞻性作用。
帕金森病(PD)是一种影响全球数百万人的神经退行性疾病。帕金森病会导致令人衰弱的运动和认知症状,如震颤、僵直和行走困难。目前治疗帕金森病的方法都是治标不治本。因此,迫切需要更好的管理和深入研究替代疗法。间充质干细胞(MSC)疗法是这些前景广阔的疗法中的主要竞争者之一。我们研究了证明间充质干细胞具有神经保护、抗炎和再生特性的临床前和临床证据。这篇综述重点探讨了帕金森病复杂的病理生理机制,以及间充质干细胞及其衍生物(如分泌物和外泌体)在帕金森病临床治疗中的前景。我们还分析了每种方法所面临的挑战和局限性,包括给药方法、给药时机和长期安全性考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Parkinsonism & related disorders
Parkinsonism & related disorders 医学-临床神经学
CiteScore
6.20
自引率
4.90%
发文量
292
审稿时长
39 days
期刊介绍: Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.
期刊最新文献
Letter to the editor: TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome. Short-term cognitive practice effects in Parkinson's disease: More than meets the eye. Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings. Evaluation of mild cognitive impairment in older patients with essential tremor. NDUFAF5 variants cause early onset Leigh syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1